Annaly Capital Management Other Income (Expense) decreased by 145.7% to -$253.68M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 58.9%, from -$159.66M to -$253.68M. Over 3 years (FY 2021 to FY 2025), Other Income (Expense) shows a downward trend with a -9.5% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$566.96M | $181.18M | $77.76M | $1.48B | $397.90M | -$585.07M | -$883.32M | $175.48M | -$559.45M | -$384.30M | $406.38M | -$113.47M | -$2.86M | $224.59M | -$159.66M | -$289.47M | $483.58M | $555.18M | -$253.68M |
| QoQ Change | — | +132.0% | -57.1% | >999% | -73.2% | -247.0% | -51.0% | +119.9% | -418.8% | +31.3% | +205.7% | -127.9% | +97.5% | >999% | -171.1% | -81.3% | +267.1% | +14.8% | -145.7% |
| YoY Change | — | — | — | — | +170.2% | -422.9% | -159.5% | -55.9% | +4.4% | — | +146.0% | -164.7% | +99.5% | +158.4% | -139.3% | -155.1% | >999% | +147.2% | -58.9% |
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Agency | -$184.91M | -$6.66M | $272.31M | -$166.93M | -$252.85M | $495.45M | $601.76M | -$334.54M |
| Residential Credit | $48.46M | $36.03M | — | $12.09M | -$193.00K | $32.34M | — | $144.36M |
| MSR | $22.32M | -$33.97M | -$6.82M | -$2.96M | -$39.37M | -$45.91M | -$13.34M | -$62.80M |
| Total | -$113.47M | -$2.86M | $224.59M | -$159.66M | -$289.47M | $483.58M | $555.18M | -$253.68M |